Product information

Lamisil 250 mg
56
terbinafine
0292177
0 / 10
Locked

Product properties

91161-71-6
D01BA02
Novartis Pharma
Tablet
€30.04
BE155705
07612797321362
M1
Public
155705-02

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Commercial reasons) and no stock is available from wholesalers. Switching to an alternative is necessary.

Recommended alternative

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives

Status history (PharmaStatus)

Commercialization stopped Active
- present

Commercial reasons

Alternative available

Composition

2 ingredients

Substance Type Strength CAS
Active ingredient
281.25 mg
78628-80-5
Excipient
44.85 mg

Additional information

View on BCPI

Availability statistics

Commercialization stopped
364 days
1
0
01/06/2025